Biography
Dr. Nath is a cancer biologist with expertise in both experimental and computational biology. Through the integration of bioinformatics and artificial intelligencemachine learning (AIML) tools, his research aims to unravel the underlying mechanisms of tumor progression and establish cutting-edge biomarkers for improving the clinical outcomes of patients with cancer.Dr. Nath's research employs both bulk and single-cell multi-omics approaches to identify the mechanisms behind tumor evolution and the subsequent development of drug resistance. Dr. Nath aspires to translate research findings into clinical impact, notably contributing to breast cancer treatment with novel prognostic AIML biomarkers. These biomarkers are now part of clinical trials for optimized treatment strategies in metastatic breast cancer patients.Throughout his career, Dr. Nath has had the privilege to work in close collaboration with laboratory scientists, mathematicians, and medical oncologists. At City of Hope, Dr. Nath leads a collaborative research team that investigates the potential of AIML in enhancing cancer patient outcomes. Dr. Nath currently is a principal investigator (PI) of a National Cancer InstituteNational Institute of Health (NCINIH) U01 grant, multiple NCINIH administrative supplements, a PHASE ONE foundation grant, a JKTG foundation grant, and co-investigator of a California Institute for Regenerative Medicine (CIRM) grant.